MAM
ARMP icon

Madison Asset Management’s Armata Pharmaceuticals ARMP Stock Holding History

Madison Asset Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
2,107,175
-500
-0% -$4.58K 0.16% 120
2026
Q1 		$21.6M Buy
+2,107,675
New +$17.7M 0.27% 94

Other funds holding ARMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Madison Asset Management's ARMP Position: Q2 2026 in Review

Madison Asset Management reduced its Armata Pharmaceuticals (ARMP) stake by 0.02% in Q2 2026, selling an estimated $4.58K and leaving 2,107,175 shares worth $13.7M. The position accounts for 0.16% of the portfolio, ranked #120.

Madison Asset Management first reported a position in ARMP in Q1 2026 and has held it in 2 quarters since. The position peaked at $21.6M in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Madison Asset Management held 2,107,175 shares of Armata Pharmaceuticals worth $13.7M as of Q2 2026.
  • Madison Asset Management sold 500 Armata Pharmaceuticals shares in Q2 2026, an estimated $4.58K.
  • Armata Pharmaceuticals made up 0.16% of Madison Asset Management's portfolio in Q2 2026, its #120 holding.
  • Madison Asset Management first reported a position in Armata Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Madison Asset Management's Armata Pharmaceuticals position peaked at $21.6M in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Madison Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.